leisure time -WSS

leisure time

author：leisure time 2025-09-06 04:27:28 - browse：92

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： EPA limits use of carcinogenic gas for sterilizing medical devices

hotspot

WSS

Change Healthcare outage fallout shows need for new oversight

How many hemophilia patients actually want gene therapy?

Merck, Daiichi strike cancer drug pact worth up to $22 billion

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

How to save health care price transparency rules

Is there really a nursing shortage in the U.S.?

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast: Live from the 2023 STAT Summit

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: Live from the 2023 STAT Summit

Moonlake's readout produced a cash windfall. Risks remain

STAT Summit: Meghan O’Rourke on making chronic illness visible

BioMarin wins approval for gene therapy to treat hemophilia A

Health tech investors get more selective as pandemic boom fades

explore

STAT Summit: Meghan O’Rourke on making chronic illness visible

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Male and female sex labels in research insufficient, scientists say

UnitedHealth, Optum discontinue NaviHealth name

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

explore

hotspot

entertainment

explore